Fig. 3From: Cost-effectiveness of response evaluation after chemoradiation in patients with advanced oropharyngeal cancer using 18F–FDG-PET-CT and/or diffusion-weighted MRITotal number of EUA indications, number of unnecessary EUA indications and expected costs per patient per strategy for 1000 patientsBack to article page